Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
The Corticosteroid Receptor Hypothesis of Depression
2000 Standout
Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men
1998
Acromegaly
2006 Standout
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus
2000 Standout
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
2016 Standout
Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide
2010
The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function
2005
Cardiovascular involvement in patients affected by acromegaly: An appraisal
2012
CALCITONIN GENE‐RELATED PEPTIDE MEDIATES THE CARDIOPROTECTIVE EFFECTS OF RUTAECARPINE AGAINST ISCHAEMIA–REPERFUSION INJURY IN SPONTANEOUSLY HYPERTENSIVE RATS
2008
Role of C-Reactive Protein at Sites of Inflammation and Infection
2018 Standout
Endocrine Mechanisms of Blood Pressure Rhythms
1996
Anandamide – the other side of the coin
2000 StandoutNobel
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
2018
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
2007 Standout
Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism
2009
Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats
2003
Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study
2002
Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy Volunteers
2001
Sex differences in HPA axis responses to stress: a review
2004 Standout
Chronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy
2012
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
2003
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Relationship between blood pressure and glucose tolerance in acromegaly
2001
miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas
2005
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women
2009
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Atrial Natriuretic Factor: Implications for Cardiac Pacing and Electrophysiology
1994
Effects of angiotensin-II infusion at pressor and subpressor doses on endothelbv-1 plasma levels in healthy men
1997
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension
2006
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Sarcopenia
2019 Standout
Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension
2013
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
2012
MicroRNA signatures in human cancers
2006 Standout
Low-dose oral or non-oral hormone therapy: effects on C-reactive protein and atrial natriuretic peptide in menopause
2014
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
2015 StandoutNobel
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids
2010
Ghrelin: Structure and Function
2005 Standout
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
2017 Standout
A Serum Shock Induces Circadian Gene Expression in Mammalian Tissue Culture Cells
1998 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
2014
A meta-analysis of cortisol response to challenge in human aging: importance of gender
2004
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder
1996
Recent advances in the study on capsaicinoids and capsinoids
2010 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Muscle Sympathetic Nerve Activity in Patients with Acromegaly
2000
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Predicting Alzheimer disease from a blood-based biomarker profile
2016 StandoutNobel
Exercise and Physical Activity for Older Adults
2009 Standout
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function
1996
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Opioid control of LH secretion in humans: Menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine.
1986
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Galanin in the regulation of the hypothalamic-pituitary-adrenal axis (Review)
2007
Hypothalamic-Pituitary-Adrenocortical Axis Changes in a Transgenic Mouse with Impaired Glucocorticoid Receptor Function*
1997
Asymmetrical Reduction of the Nociceptive Flexion Reflex Threshold in Cluster Headache
2000
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
The Role of Clock Genes in Pharmacology
2010
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Inhibitory Effects of Somatostatin Analogs on Prolactin Secretion in Rats Pretreated with Estrogen or Haloperidol
1987 Nobel
Social and Emotional Aging
2009 Standout
Opioid Complications and Side Effects
2008 Standout
Morphine inhibits cortisol and stimulates prolactin secretion in man
1984
Guidelines for the management of thyroid cancer
2014 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.
2015 Standout
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
2009
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Neuroendocrine Control of Growth Hormone Secretion
1999
Responses of total and free insulin‐like growth factor‐I and insulin‐like growth factor binding protein‐3 after resistance exercise and training in elderly subjects
1999
Works of Angelo Margutti being referenced
Growth Hormone Excess Promotes Breast Cancer Chemoresistance
2009
Somatostatin Receptor Subtype 1 Selective Activation in Human Growth Hormone (GH)- and Prolactin (PRL)-Secreting Pituitary Adenomas: Effects on Cell Viability, GH, and PRL Secretion
2003
Function of the GH/IGF-1 Axis in Healthy Middle-Aged Male Runners
1996
Unexpected Activation of Pituitary-Adrenal Axis in Healthy Young and Elderly Subjects during Somatostatin Infusion
1998
Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man
1995
Diurnal Rhythm of Plasma Catecholamines in Acromegaly1
1999
Differential effects of deltorphin on arginine and galanin-induced growth hormone secretion in healthy man
1995
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension
1992
Circadian Rhythms of Atrial Natriuretic Peptide, Blood Pressure and Heart Rate in Normal Subjects
1989
Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women
1997
Activation of the Somatotropic Axis by Testosterone in Adult Men: Evidence for a Role of Hypothalamic Growth Hormone-Releasing Hormone
2003
Stimulation of growth hormone and corticotropin release by angiotensin II in man
1990
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects
1990
Blood Growth Hormone-Binding Protein Levels in Premenopausal and Postmenopausal Women: Roles of Body Weight and Estrogen Levels1
2001
Defective Hypothalamic Growth Hormone (GH)-Releasing Hormone Activity May Contribute to Declining GH Secretion with Age in Man1
1997
Selective Activation of Somatostatin Receptor Subtypes Differentially Modulates Secretion and Viability in Human Medullary Thyroid Carcinoma Primary Cultures: Potential Clinical Perspectives
2006
Circadian Profile of Plasma Calcitonin Gene-Related Peptide in Healthy Man*
1991
Atrial strain is the main determinant of release of atrial natriuretic peptide
1990
Acute Administration of Human Galanin in Normal Subjects Reduces the Potentiating Effect of Pyridostigmine-lnduced Cholinergic Enhancement on Release of Norepinephrine and Pancreatic Polypeptide
1996
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man.
1992
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man.
1993
Dermorphin inhibits spinal nociceptive flexion reflex in humans
1986
Stress-induced activation of sympathetic nervous system is attenuated by the delta-opioid receptor agonist deltorphin in healthy man.
1993
Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomas in Vitro
2004
Effect of Pentagastrin on Adrenocorticotropin Hormone and Thyroid-Stimulating Hormone Release in Normal Subjects
1983
Human galanin reduces plasma norepinephrine levels in man.
1995
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids
1985
Growth Hormone Excess Promotes Breast Cancer Chemoresistance
2009
Effect of somatostatin on growth hormone and prolactin response to dermorphin in man
1985
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man.
1994
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects*
1983